MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 421 filers reported holding MEDIVATION INC in Q2 2016. The put-call ratio across all filers is 0.92 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $329,000 | +327.3% | 5,460 | +225.6% | 0.01% | +300.0% |
Q1 2016 | $77,000 | -4.9% | 1,677 | 0.0% | 0.00% | -25.0% |
Q4 2015 | $81,000 | +39.7% | 1,677 | +23.6% | 0.00% | -20.0% |
Q3 2015 | $58,000 | +866.7% | 1,357 | +2669.4% | 0.01% | – |
Q2 2015 | $6,000 | 0.0% | 49 | 0.0% | 0.00% | – |
Q1 2015 | $6,000 | 0.0% | 49 | -22.2% | 0.00% | -100.0% |
Q4 2014 | $6,000 | 0.0% | 63 | -3.1% | 0.00% | 0.0% |
Q3 2014 | $6,000 | -75.0% | 65 | -79.4% | 0.00% | -66.7% |
Q2 2014 | $24,000 | -40.0% | 315 | -50.0% | 0.00% | 0.0% |
Q1 2014 | $40,000 | – | 630 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 4,397,838 | $212,591,000 | 78.82% |
HealthCor Management, L.P. | 2,300,000 | $111,182,000 | 6.75% |
Redmile Group, LLC | 1,599,393 | $77,315,000 | 5.79% |
Marcus Capital, LLC | 104,900 | $5,071,000 | 5.39% |
BB BIOTECH AG | 2,581,112 | $124,771,000 | 3.52% |
Hatteras Investment Partners, LP | 47,150 | $2,279,000 | 2.98% |
Opus Point Partners Management, LLC | 91,310 | $4,414,000 | 2.92% |
TORRAY INVESTMENT PARTNERS LLC | 793,000 | $38,334,000 | 2.85% |
Selkirk Management LLC | 92,000 | $4,447,000 | 2.62% |
MONTAGE INVESTMENTS, LLC | 25,520 | $1,234,000 | 2.43% |